UK-based healthtech startup developing a supported alcohol reduction platform that combines clinical care and prescription medication
Nul has raised €844k across 1 funding round from 3 investors, most recently a Seed round in Feb 2026. Based in London, UK; active in Healthtech. Data as of 7 Aug 2026.
Timing: too soon vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-02-16 | Seed | €844k |
| Angel Investors,BYVP,dmg ventures |
| View deal → |
